These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1829715)

  • 21. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cut costs, minister warns Alberta physicians and patients.
    Morningstar L
    CMAJ; 1986 Nov; 135(10):1180, 1184-5. PubMed ID: 3768827
    [No Abstract]   [Full Text] [Related]  

  • 25. Health care insurance premiums project.
    Mich Med; 1999 Feb; 98(2):19-21. PubMed ID: 10074773
    [No Abstract]   [Full Text] [Related]  

  • 26. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost and utilization of alcoholism treatment under health insurance. A review of three studies.
    Ryan K
    Alcohol Health Res World; 1984-1985 Winter; 9(2):45-52, 72. PubMed ID: 10270903
    [No Abstract]   [Full Text] [Related]  

  • 28. "High-cost" employees in an occupational alcoholism program. A preliminary report.
    Burton WN; Eggum PR; Keller PJ
    J Occup Med; 1981 Apr; 23(4):259-62. PubMed ID: 7218064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health insurance coverage for alcoholism: a review of costs and utilization.
    Hallan JB
    Alcohol Health Res World; 1981; 5(4):16-21. PubMed ID: 10252094
    [No Abstract]   [Full Text] [Related]  

  • 30. How does Cash and Counseling affect costs?
    Dale SB; Brown RS
    Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of alcohol treatment and costs after implementation of medicaid managed care.
    Rothbard AB; Kuno E
    Am J Manag Care; 2006 May; 12(5):285-96. PubMed ID: 16686586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
    Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financial costs of alcoholism treatment programs: a longitudinal and comparative evaluation among four specialized centers.
    Nalpas B; Combescure C; Pierre B; Ledent T; Gillet C; Playoust D; Danel T; Bozonnat MC; Martin S; Balmès JL; Daurès JP
    Alcohol Clin Exp Res; 2003 Jan; 27(1):51-6. PubMed ID: 12544005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
    Zámbori J; Szádóczky E; Rózsa S; Füredi J
    J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconsidering the moral hazard-risk avoidance tradeoff.
    Newhouse JP
    J Health Econ; 2006 Sep; 25(5):1005-14. PubMed ID: 16860893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization and cost of mental health, substance abuse, and medical services among at-risk drinkers.
    Nietert PJ; French MT; Kirchner JE; Booth BM
    Med Care Res Rev; 2007 Aug; 64(4):431-48. PubMed ID: 17684111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in alcoholism treatment research.
    Neonatal Netw; 1992 Apr; 11(3):50-2. PubMed ID: 1574046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.